SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-18-000092
Filing Date
2018-11-07
Accepted
2018-11-07 16:14:23
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq32018.htm 10-Q 744820
2 AMENDMENT TO BEVERS EMPLOYMENT AGREEMENT denisebeversamendmentno1to.htm EX-10.1 14925
3 EXHIBIT 31.1 exhibit311q32018.htm EX-31.1 14031
4 EXHIBIT 31.2 exhibit312q32018.htm EX-31.2 14050
5 EXHIBIT 32.1 exhibit321q32018.htm EX-32.1 8148
  Complete submission text file 0001561743-18-000092.txt   4487860

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kin-20180930.xml EX-101.INS 1009587
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20180930.xsd EX-101.SCH 30072
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20180930_cal.xml EX-101.CAL 57425
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20180930_def.xml EX-101.DEF 160631
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20180930_lab.xml EX-101.LAB 435797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20180930_pre.xml EX-101.PRE 257993
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 181166499
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1